As global markets navigate a landscape marked by interest rate adjustments and mixed economic signals, growth stocks have continued to outperform their value counterparts, particularly in the technology sector. Amidst these shifts, insider ownership can serve as a compelling indicator of confidence in a company's potential to thrive; companies with significant insider stakes often signal strong alignment between management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership
| Name | Insider Ownership | Earnings Growth |
| People & Technology (KOSDAQ:A137400) | 16.4% | 37.3% |
| Archean Chemical Industries (NSEI:ACI) | 22.9% | 41.3% |
| Kirloskar Pneumatic (BSE:505283) | 30.3% | 26.3% |
| Seojin SystemLtd (KOSDAQ:A178320) | 30.9% | 39.9% |
| Medley (TSE:4480) | 34% | 31.7% |
| Laopu Gold (SEHK:6181) | 36.4% | 34.2% |
| Brightstar Resources (ASX:BTR) | 16.2% | 84.5% |
| Fine M-TecLTD (KOSDAQ:A441270) | 17.2% | 131.1% |
| HANA Micron (KOSDAQ:A067310) | 18.5% | 110.9% |
| Findi (ASX:FND) | 34.8% | 112.9% |
Let's take a closer look at a couple of our picks from the screened companies.
RaySearch Laboratories (OM:RAY B)
Simply Wall St Growth Rating: ★★★★★☆
Overview: RaySearch Laboratories AB (publ) is a medical technology company that offers software solutions for cancer care across various regions including the Americas, Europe, Africa, the Asia-Pacific, and the Middle East, with a market cap of SEK7.03 billion.
Operations: The company generates revenue of SEK1.17 billion from its healthcare software segment.
Insider Ownership: 23.6%
RaySearch Laboratories has demonstrated strong growth, with earnings increasing by 172.8% over the past year and expected to grow 24.1% annually, outpacing the Swedish market's forecasted growth of 14.6%. Recent client orders from major institutions like Institut Curie and GenesisCare UK underscore its expanding market presence. The recent appointment of a new CFO suggests strategic leadership changes as it continues leveraging its high insider ownership to drive innovation in oncology treatment planning systems.
- Delve into the full analysis future growth report here for a deeper understanding of RaySearch Laboratories.
- In light of our recent valuation report, it seems possible that RaySearch Laboratories is trading beyond its estimated value.
Surgical Science Sweden (OM:SUS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training globally, with a market cap of approximately SEK7.88 billion.
Operations: The company's revenue is derived from two main segments: Industry/OEM, contributing SEK419.66 million, and Educational Products, accounting for SEK440.17 million.
Insider Ownership: 26.6%
Surgical Science Sweden is poised for significant earnings growth, forecasted at 36.1% annually, surpassing the Swedish market's 14.6%. Despite revenue growth of 17.7% per year being slower than its earnings trajectory, it remains above the national average. The company trades at a substantial discount to its estimated fair value and has recently engaged in multiple global presentations, enhancing visibility in healthcare simulation technology markets despite recent declines in net income and EPS compared to last year.
- Take a closer look at Surgical Science Sweden's potential here in our earnings growth report.
- Our comprehensive valuation report raises the possibility that Surgical Science Sweden is priced lower than what may be justified by its financials.
Vercom (WSE:VRC)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Vercom S.A. develops cloud communications platforms and has a market cap of PLN2.66 billion.
Operations: The company's revenue is primarily derived from its Cpaas segment, which generated PLN462.07 million.
Insider Ownership: 12.7%
Vercom's earnings are projected to grow significantly at 21.91% annually, outpacing the Polish market's 16.1%. Recent third-quarter results showed a strong performance with sales reaching PLN 145.11 million, up from PLN 84.93 million last year, and net income increasing to PLN 19.4 million from PLN 13.05 million. Despite revenue growth forecasts of just 13.6% per year, Vercom trades slightly below its fair value estimate and maintains high insider ownership without recent substantial insider trading activity.
- Click to explore a detailed breakdown of our findings in Vercom's earnings growth report.
- Upon reviewing our latest valuation report, Vercom's share price might be too optimistic.
Make It Happen
- Investigate our full lineup of 1529 Fast Growing Companies With High Insider Ownership right here.
- Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.
- Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About WSE:VRC
Outstanding track record with high growth potential.
